THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Kenichi Tanaka to Whole Blood Coagulation Time

Back to Details
This is a "connection" page, showing publications Kenichi Tanaka has written about Whole Blood Coagulation Time.
Kenichi Tanaka
Connection Strength
0.436
Whole Blood Coagulation Time
  1. Low ACT After High-Dose Heparin: Is Hemodilution Best Option to Pass by Syclla and Charybdis? A A Pract. 2019 12 15; 13(12):479.
    View in: PubMed
    Score: 0.173
  2. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients. Anesth Analg. 2012 Aug; 115(2):244-52.
    View in: PubMed
    Score: 0.102
  3. The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg. 2004 Nov; 99(5):1283-1289.
    View in: PubMed
    Score: 0.061
  4. Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. Thromb Res. 2004; 113(5):333-9.
    View in: PubMed
    Score: 0.057
  5. Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran. Anesth Analg. 2020 02; 130(2):535-541.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES